THE US Food and Drug
Administration has approved
Juvisync, a fixed-dose combination
prescription medication that
contains two previously FDA
approved medicines in one tablet,
sitagliptin and simvastatin, to treat
diabetes and high cholesterol.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Oct 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Oct 11
TELSTRA Health is set to acquire the remaining 50% stake in Fred IT Group, an Australian technology provider for the pharmacy sector (PD breaking news).
THE availability of first-line oral emergency contraceptives in Australian community pharmacies is concerning, with a national survey revealing that nearly one-third of pharmacies do not stock the ulipristal acetate pill, according to Flinders University.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.